Connect with us

Technology

JoySauce Taps Cineverse’s Matchpoint™ to Deliver ‘American Asian’ Content to Streaming Platforms and Launch New Branded App

Published

on

Matchpoint™ – Cineverse’s Complete OTT Solution – to Empower JoySauce to Efficiently Deliver its Original Series and Licensed Content for Distribution via SVOD, AVOD and FAST

LOS ANGELES, Jan. 28, 2025 /PRNewswire/ — Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, today announced that Matchpoint™, its proprietary streaming technology platform, is being used by JoySauce through a new strategic partnership. JoySauce – a leading lifestyle company for American Asians and their non-Asian family members, friends, and allies – is tapping into the full Matchpoint suite to license, monetize and distribute their full library of exclusive and original series and other curated, premium content. 

Starting immediately, JoySauce will use Matchpoint to ingest the library of original dramatic shows, reality series and more – along with third-party content for which JoySauce holds streaming rights – which will initially be licensed to leading streaming platforms.

In phase two of this partnership, later in 2025, Cineverse will help create a new standalone streaming service, including a branded JoySauce subscription video-on-demand (SVOD) app and eventually a free, ad-supported streaming television (FAST) channel targeting both the AAPI community and all viewers interested in content showcasing the American Asian experience.  These will be made available by Cineverse on all devices and offered to other streaming platforms.

Jonathan Ng Sposato, founder of Joy Sauce commented: “Cineverse is the proven expert we need to make our streaming goals a reality. As a one-stop shop for licensing, tech and advertising, Matchpoint allows us to focus on creating the content that we want to bring to our audience, and fill a void that currently exists for premium American Asian streaming programming. We look forward to Cineverse being part of our journey to super-serve an audience that is hungry for original and entertaining shows curated specifically with it in mind.”

The JoySauce content now available to be licensed through Cineverse for streaming is a mix of original productions and acquired content spanning comedy, drama, unscripted and variety, with more originals to be announced in the near future.  This includes:

Mixed Six – In this JoySauce original, six mixed heritage couples open up about their meet-cute moments, what it was like introducing their families, and the joys and complexities of growing up American and Asian.

VeryAsianConversations – In this JoySauce original, prominent social movement catalyst and Korean American newscaster Michelle Li, who has turned a racist event into a national phenomenon called #VeryAsian, sits down with JoySauce for a bite-sized series on relevant Asian American issues like transracial adoption, reclaiming Asian names, and combating anti-Asian hate.

Kim’s Convenience – Starring Simu Liu, Kim’s Convenience tells the hilarious and heartfelt story of the Kim family, Korean Canadian convenience store owners who have worked hard to give their now-twenty-something children, Janet and Jung, a better life. This award winning comedy finds laughter in the trials of running a literal ‘Mom and Pop’ shop while the younger generation comes of age straddling cultures old and new.

Jimmy O. Yang Good Deal – Performed live at the Neptune Theater in Seattle, Washington, Jimmy O. Yang covers hilarious interactions with immigrant parents, his thoughts on Matt Damon, and whether ghosts will haunt one-bedroom apartments.

Project Gutenberg – Award-winning Hong Kong thriller following a counterfeit artist whose past draws him into a high-stakes police investigation. Written and directed by Felix Chong (Infernal Affairs) and starring Chow Yun-fat (Crouching Tiger, Hidden Dragon).

Bulge Bracket – In the high-intensity world of mergers, acquisitions, and IPOs, recent b-school graduate Cathy Lee (Jessika Van, CBS’s Rush Hour) begins her career at a prestigious New York investment bank. Similar in tone to HBO’s Silicon Valley or The Office, this ensemble dramedy finds humor in high-stress situations at the office, as it explores the costs of climbing the corporate ladder while not losing one’s identity.

“The content JoySauce is curating is important, timely and fills a need in the marketplace. We expect our distribution partners to be excited for the opportunity to reach a young and engaged audience through JoySauce across all of their platforms and channels,” said Cineverse EVP Partnerships Marc Rashba.

About JoySauce

Exuberant, joyful, and positive, JoySauce is the first and only digital network dedicated to the AAPI experience.  It playfully imagines a delightful parallel universe where portrayals of “American Asians” are always positive, beautiful, funny, strong, and cool. Bolstered by a lineup of new originally produced AAPI series and award winning films exclusive to JoySauce, combined with Asian pop culture entertainment, much of the content is available nowhere else in the FAST or VOD ecosystem.  It is both a voice for the underserved 24 million Asian American Pacific Islanders while 100% appealing to the broader general market and its rising demand for eclectic Asian pop culture content.  Going well beyond Korean serial dramas or martial arts period pieces, JoySauce reframes the status quo, blows away old tropes, and creates a fresh new culture of AAPI entertainment. For more information, visit www.joysauce.com

About Cineverse Technologies

Cineverse develops technology that powers the future of entertainment. Its proprietary Matchpoint™ suite of streaming technology and AI tools – first utilized to build the company’s owned-and-operated services and now offered to third parties as a SaaS solution – supports filmmakers, media companies, platforms and OEMs. cineSearch, the AI-powered search and discovery tool for film and television, makes deciding what to watch as entertaining as the entertainment itself. Additionally, the C360 programmatic audience network and ad-tech platform provides brands the opportunity to target and reach key fandoms wherever they are.

About Cineverse

Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts.  Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing non-rated film in U.S. history; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more.  Powering visionary storytelling with cutting-edge innovation, Cineverse’s proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit home.cineverse.com.

Contacts:

For Media
The Lippin Group, cineverse@lippingroup.com

For Investors
Julie Milstead, investorrelations@cineverse.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/joysauce-taps-cineverses-matchpoint-to-deliver-american-asian-content-to-streaming-platforms-and-launch-new-branded-app-302360507.html

SOURCE Cineverse Corp.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending